0001209191-15-032284.txt : 20150403
0001209191-15-032284.hdr.sgml : 20150403
20150403162248
ACCESSION NUMBER: 0001209191-15-032284
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150401
FILED AS OF DATE: 20150403
DATE AS OF CHANGE: 20150403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Coherus BioSciences, Inc.
CENTRAL INDEX KEY: 0001512762
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273615821
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O DENNIS M. LANFEAR
STREET 2: 201 REDWOOD SHORES PARKWAY, SUITE 200
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: (650) 649-3530
MAIL ADDRESS:
STREET 1: C/O DENNIS M. LANFEAR
STREET 2: 201 REDWOOD SHORES PARKWAY, SUITE 200
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: BioGenerics, Inc.
DATE OF NAME CHANGE: 20110210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wahlstrom Mats
CENTRAL INDEX KEY: 0001459154
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36721
FILM NUMBER: 15751508
MAIL ADDRESS:
STREET 1: 500 GOLDEN RIDGE ROAD, SUITE 100
CITY: GOLDEN
STATE: CO
ZIP: 80401
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-04-01
0
0001512762
Coherus BioSciences, Inc.
CHRS
0001459154
Wahlstrom Mats
C/O COHERUS BIOSCIENCES, INC.
201 REDWOOD SHORES PARKWAY, SUITE 200
REDWOOD CITY
CA
94065
1
0
0
0
Common Stock, $0.0001 par value
709482
I
See Footnote
Common Stock, $0.0001 par value
53583
I
See Footnote
Stock Option (Right to Buy)
29.00
2015-04-01
4
A
0
20000
0.00
A
2025-03-31
Common Stock
20000
20000
D
Stock Option (Right to Buy)
29.00
2015-04-01
4
A
0
75000
0.00
A
2025-03-31
Common Stock
75000
75000
D
The shares are held by KMG Capital Partners, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by KMG Capital Partners, LLC except to the extent of his pecuniary interest therein.
The shares are held by Leonard Capital, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein.
The underlying shares subject to the option vest and become exercisable in full on the earlier of (i) one year from the 2015 Annual Meeting scheduled for May 21, 2015, or (ii) the date of the 2016 Annual Meeting, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.
Option granted to Reporting Person pursuant to his position as Chairman of the Audit Committee and Lead Independent Director. The underlying shares subject to the option vest and become exercisable in full on the earlier to occur of (i) one year from the 2015 Annual Meeting to be held on May 21, 2015, or (ii) the date of the 2016 Annual Meeting, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.
/s/ Matthew R. Hooper, as Attorney-in-Fact for Mats Wahlstrom
2015-04-03